
Daiichi Sankyo Co Ltd
ESG ratings & risk scores
ESG Solutions

Daiichi Sankyo Co Ltd ESG Profile
✓ Multi-Provider CoverageAt a glance
Verified June 2026ESG & Sustainability Profile
Key Facts
- • 2005.
Daiichi Sankyo Co., Ltd. is a leading pharmaceutical company based in Japan, specializing in antibody drug conjugates (ADCs). With a low ESG risk rating score of 19.8, Daiichi Sankyo has been a key player in the healthcare industry since the merger of Daiichi Pharmaceuticals and Sankyo in 2005. Their primary growth drivers include key ADCs such as Enhertu (HER2), Dato-DXd (TROP2), I-DXd (B7-H3), HER3-DXd (HER3), and R-DXd (CDH6). Enhertu, for example, has received approvals for various types of cancer, including HER2-positive breast, stomach, and non-small cell lung cancers. As Daiichi Sankyo expands its global presence, the company's revenue from Japan is expected to decrease over time.
Key Insights
Key Insights
Covered by 3 ESG rating providers
Strong coverage
Net Zero target: 2050
24 years to achieve
Science Based Targets approved
Validated emissions reduction pathway
Sustainability Commitments & Climate Targets
Daiichi Sankyo Co Ltd ESG Rating Coverage - Sustainalytics & LSEG
Analyzed by both major ESG rating providers - verified
| Provider | Coverage | Details |
|---|---|---|
Morningstar Sustainalytics ESG Risk Ratings | Covered | |
LSEG (Refinitiv) ESG Scores & Data | Covered |
Coverage verified from 2 of 2 active providers.
ESG Rating Provider Coverage
MSCI ESG Ratings
Measures company exposure to industry-specific ESG risks and management of those risks relative to peers.
MSCI identifies the ESG risks most relevant to each industry, then scores companies on how well they manage those risks compared to peers. Ratings range from AAA (leader) to CCC (laggard) and are reviewed annually.
View on MSCIMorningstar Sustainalytics ESG Risk Ratings
Assesses the degree to which a company's economic value is at risk driven by ESG factors.
Sustainalytics measures unmanaged ESG risk — the gap between a company's total exposure to material ESG issues and how much of that exposure its management practices address. Lower scores indicate less unmanaged risk.
View on SustainalyticsLSEG (Refinitiv) ESG Scores
Evaluates company ESG performance based on publicly available, verifiable data across 630+ metrics.
LSEG scores companies across 630+ ESG data points drawn entirely from public disclosures — annual reports, sustainability filings, and regulatory submissions. Scores are weighted by industry materiality and benchmarked against sector peers.
View on LSEGCoverage status indicates whether publicly available ESG data from each provider has been identified for Daiichi Sankyo Co Ltd. For official ratings and scores, visit provider websites directly.
ESG Solutions for HealthCare
Syndio
Syndio empowers enterprises with AI-powered compensation workflows, ensuring fair pay decisions and compliance with EUPTD standards.
Eskalera
Eskalera provides advanced tools for enhancing workplace diversity, equity, and inclusion, driving positive social impact.
Inclusion Score
Inclusion Score offers innovative tools to enhance diversity, equity, and inclusion in organizations worldwide.
Trusaic
Trusaic offers trusted pay equity and transparency solutions, helping businesses comply with DEI regulations globally.
Edge Certification
Edge Certification provides comprehensive social governance solutions to promote gender equality and sustainable practices globally.
tEQuitable
tEQuitable provides tools and insights to foster equitable workplaces, enhancing social governance and workplace culture.